Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) just unveiled an announcement.
Vitrafy Life Sciences will present at the NWR Virtual Healthcare Conference, with Managing Director and CEO Brent Owens scheduled to speak in an online session on 26 March 2026. The company is providing live access, a subsequent recording through its website and social media, and opportunities for investors and stakeholders to submit questions, underscoring its push to raise visibility of its cryopreservation technology and engage the healthcare investment community.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.40 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is an ASX-listed life sciences company that has developed breakthrough cryopreservation technology aimed at dramatically improving cell survival rates across multiple applications. Its solutions target blood platelets, cell and gene therapies, aquaculture and bovine reproduction through FDA-registered Smart Freezing and Smart Thawing devices, an integrated LifeChain software platform and Smart Packaging systems delivered via a managed service revenue model.
Average Trading Volume: 32,746
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$101.5M
See more insights into VFY stock on TipRanks’ Stock Analysis page.